202
Participants
Start Date
October 30, 2024
Primary Completion Date
April 18, 2025
Study Completion Date
May 2, 2025
Placebo
"0 mg (Placebo). Participants will receive three bottles, each containing 35 tablets with placebo tablets.~Participants will take 1 tablet from each bottle on each scheduled day of study intervention, which will provide the placebo dose."
AZD0780
"Dose 1 Participants will receive three bottles, each containing 35 tablets:~* 1 bottle of dose a AZD0780 tablets~* 1 bottle of dose b AZD0780 tablets~* 1 bottle of dose c AZD0780 tablets Participants will take 1 tablet from each bottle on each scheduled day of study intervention, which will provide the AZD0780 dose."
Research Site, New Windsor
Research Site, Horsham
Research Site, Potomac
Research Site, Spartanburg
Research Site, Port Orange
Research Site, Jacksonville
Research Site, Hialeah
Research Site, Miami
Research Site, Miami
Research Site, Miami
Research Site, Miami
Research Site, Tamarac
Research Site, Boca Raton
Research Site, Ocala
Research Site, Beavercreek
Research Site, Chicago
Research Site, Mesquite
Research Site, Dallas
Research Site, Paris
Research Site, Hurst
Research Site, Austin
Research Site, El Paso
Research Site, Inglewood
Research Site, Northridge
Research Site, Pomona
Research Site, New Bedford
Lead Sponsor
Collaborators (1)
Fortrea
INDUSTRY
AstraZeneca
INDUSTRY